Ibrutinib-MPEA is an Ibrutinib derivative targeting Bruton's tyrosine kinase (BTK), a key regulator in B cell receptor signaling. As a covalent and irreversible inhibitor, Ibrutinib-MPEA demonstrates significant biological activity against various hematological malignancies. This compound is primarily utilized in research applications focusing on cancer biology and the study of BTK-related signaling pathways.
Ibrutinib-MPEA is an Ibrutinib derivative targeting Bruton's tyrosine kinase (BTK), a key regulator in B cell receptor signaling. As a covalent and irreversible inhibitor, Ibrutinib-MPEA demonstrates significant biological activity against various hematological malignancies. This compound is primarily utilized in research applications focusing on cancer biology and the study of BTK-related signaling pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
